Vitamin B2 Metabolism Shields Cancer Cells from Programmed Destruction
Similar Articles
Cancer Vulnerability Discovered in Vitamin B7-Dependent Enzyme
High Vitamin B12 Levels Linked to Poorer Cancer Outcomes in Recent Studies
Vitamin D2 Supplements May Reduce Body's Vitamin D3 Levels
New Drugs Target 'Zombie' Cells to Combat Cancer and Aging
Leucine Amino Acid Found to Enhance Mitochondrial Energy Production
Scientists have discovered a mechanism by which vitamin B2 helps cancer cells resist a specific form of programmed cell death called ferroptosis. This finding reveals a vulnerability, as limiting vitamin B2 or using a similar bacterial compound can trigger cancer cell death. The research team is now developing new inhibitors based on this pathway for potential cancer therapies.
Facts First
- Vitamin B2 metabolism protects cancer cells from ferroptosis, an iron-dependent form of cell death.
- Limiting vitamin B2 or using roseoflavin makes cancer cells more susceptible to this destruction.
- The discovery points to a new therapeutic target for attacking cancer cells by disrupting their vitamin B2 metabolism.
- The research is part of a major European project (DeciFerr) funded by an ERC grant to develop ferroptosis-based treatments.
What Happened
Researchers at the Rudolf Virchow Centre (RVZ) discovered that vitamin B2 (riboflavin) metabolism can protect cancer cells from ferroptosis. The study, published in Nature Cell Biology, was led by Professor José Pedro Friedmann Angeli and included PhD student Vera Skafar. The team found that a protein called FSP1 is supported by vitamin B2, and cancer cells become more sensitive to ferroptosis when vitamin B2 is limited.
Why this Matters to You
This research could lead to new cancer treatments that work by cutting off the vitamin B2 supply tumors use to survive. If successful, such therapies might offer a new way to attack cancers that are resistant to current treatments. The discovery also highlights the complex role of essential nutrients, showing that while vitamin B2 is vital for general health, its metabolism might be exploited by cancer cells.
What's Next
The RVZ research team plans to develop more effective inhibitors of vitamin B2 metabolism and test them in preclinical cancer models. This work is part of the DeciFerr project, which has received significant funding from the European Research Council (ERC) through a Consolidator Grant. The broader research program is supported by the German Research Foundation (DFG) and focuses on translating the basic science of ferroptosis into clinical applications.